Related Experiment Video
Updated: Jul 10, 2026

11:28
3D Microtissues for Injectable Regenerative Therapy and High-throughput Drug Screening
Published on: October 4, 2017
10.9K
Engineering ECM-mimetic scaffolds from biological macromolecules for physiologically relevant tumoroid models
Priya Bhatt1, Prajnadipti Sahu2, Pragyan Mohapatra1
1Center for Life Sciences, Mahindra University, Hyderabad, Telangana, India; Interdisciplinary Center for Nanosensors and Nanomedicine, Mahindra University, Hyderabad, Telangana, India.
Biomaterials Advances
|March 20, 2026
Summary
Engineered biomaterial scaffolds mimicking the tumor extracellular matrix (ECM) can improve 3D tumor models. This approach enhances understanding of cancer biology and aids precision oncology development.
Area of Science:
- Biomaterials Science
- Cancer Biology
- Tissue Engineering
Background:
- The tumor extracellular matrix (ECM) is crucial for cancer cell behavior, invasion, and treatment response.
- Current 3D tumor models lack the necessary ECM cues for accurate preclinical research.
- Physiologically relevant scaffolds are needed to overcome limitations in existing tumor models.
Purpose of the Study:
- To review and synthesize knowledge on using tumor ECM macromolecules for engineering physiologically relevant scaffolds.
- To evaluate different ECM-mimetic platforms and fabrication strategies for 3D tumor models.
- To propose a framework for linking scaffold properties to tumor phenotypes and guide material selection for specific cancers.
Main Methods:
- Review of current literature on tumor ECM composition and function.
- Evaluation of various ECM-mimetic scaffold platforms (decellularized matrices, hydrogels, synthetic polymers).
- Analysis of fabrication strategies for controlling scaffold properties (stiffness, architecture, degradation).
Main Results:
- ECM macromolecules can be leveraged as modular design elements for scaffold engineering.
- Diverse ECM-mimetic platforms offer tunable properties to mimic tumor microenvironments.
- A materials-centered framework links scaffold characteristics to tumor phenotypes like EMT and drug response.
Conclusions:
- ECM-mimetic biomaterials are essential for creating advanced 3D tumor models.
- Addressing materials challenges like chemical definition and standardization is critical for translational applications.
- Engineered microenvironments are key for next-generation cancer research and precision oncology.

